Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
TB-500 is studied primarily for cell migration through actin regulation the synthetic Thymosin Beta-4 fragment's mechanism involves binding G-actin and influencing the cytoskeletal dynamics that drive cells to physically move toward sites of injury
The Increlex (mecasermin) FDA label, which covers native rhIGF-1 in pediatric severe primary IGFD, is the closest human reference and informs the contraindications below
Inactive ingredient ratings Nutrients BCP-157 Blend 1000mcg * Manufacturer does not disclose amount
The primary risk in a research setting is using an impure or improperly synthesized product, which can lead to unreliable or dangerous outcomes
US$ 28.21
US$ 27.11
US$ 25.20
US$ 25.85
US$ 25.22
